Related Experiment Video
Updated: Aug 15, 2026

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity
Published on: June 25, 2015
[Mouse neurovirulence of antigenic chimeras (type I/II) of polioviruses]
1Institute of Medical Biology, Kunming.
Abstract:
The mouse-adapted Lansing strain of poliovirus type 2 PV-2(L) induces fatal poliomyelitis in mice after intracerebral inoculation, while mice inoculated with Mahoney strain of poliovirus type 1 PV-1(M) show no signs of disease. Previous work had indicated that both the 5' non-translated region of the viral genome and the viral capsid protein, neutralization antigenic site I (N-Ag1), were involved in mouse neurovirulence. In order to further explore the role of N-Ag1 in mouse neurovirulence, antigenic chimeras of two poliovirus strains, XF414 and XF324, were constructed. In the two strains, ten amino acids (in XF414) or 16 amino acids (in XF324) in antigenic site I in Vp1 of PV-I (M) were replaced with a PV-2(L)-specific sequences using a mutagenesis cartridge. Mouse neurovirulence tests indicated that mice cerebral inoculated with XF414 and XF324 developed poliomyelitis leading to paralysis or death. The viruses possessing antigenicity of the inoculating viruses were isolated from cerebral tissues of the paralyzed mice. The results demonstrated that N-Ag1 is an important determinant of poliovirus host range, and may be involved in attachment and penetration of poliovirus (in)to cells of the mouse central nervous system.
Insights
Neutralization antigenic site I (N-Ag1) on poliovirus determines mouse neurovirulence. Replacing specific amino acids in poliovirus type 1 with poliovirus type 2 sequences induced disease in mice, confirming N-Ag1
Area of Science:
- Virology
- Neuroscience
- Immunology
Context:
- Poliovirus type 2 (PV-2) Lansing strain causes fatal neurovirulence in mice, unlike poliovirus type 1 (PV-1) Mahoney strain.
- Previous research implicated the 5' non-translated region and neutralization antigenic site I (N-Ag1) in PV-2 mouse neurovirulence.
Purpose:
- To investigate the specific role of N-Ag1 in poliovirus mouse neurovirulence.
- To construct and test chimeric poliovirus strains with modified N-Ag1 sequences.
Summary:
- Antigenic chimeras (XF414 and XF324) were created by replacing PV-1 N-Ag1 sequences with PV-2 specific sequences.
- Intracerebral inoculation of these chimeric viruses into mice resulted in poliomyelitis, paralysis, and death.
- Infected mice yielded viruses with the antigenicity of the inoculated chimeric strains, confirming viral replication.
Impact:
- Demonstrates that N-Ag1 is a critical determinant of poliovirus host range and neurovirulence in mice.
- Suggests N-Ag1 may play a role in the attachment and entry mechanisms of poliovirus into the mouse central nervous system.
- Provides insights into viral adaptation and pathogenesis, relevant for understanding poliovirus evolution and control strategies.

